Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation

Physiological Reports

Volumn 2, Issue 10, 2014, Pages

  Martineau, Corine ^a   Kevorkova, Olha ^a   Brissette, Louise ^a   Moreau, Robert ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Differentiation; HDL; MSC; Osteoblast; Osteocyte; Proliferation; SR BI; Wnt pathway

Indexed keywords

AXIN; CHOLESTEROL ESTER; DENTIN MATRIX PROTEIN 1; DICKKOPF 1 PROTEIN; ESTRADIOL; HIGH DENSITY LIPOPROTEIN 3; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LYMPHOID ENHANCER FACTOR 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR B; SCLEROSTIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; WNT3A PROTEIN; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BONE DEVELOPMENT; BONE MARROW STROMA CELL; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; MALE; MOUSE; MTT ASSAY; NONHUMAN; OSTEOCYTE; REAL TIME POLYMERASE CHAIN REACTION; WNT SIGNALING PATHWAY;

EID: 84941692374     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12117     Document Type: Article

References (60)

1. Ackert-Bicknell, C. L. 2012. HDL cholesterol and bone mineral density: is there a genetic link? Bone 50:525-533.
2. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520.
3. Agueda, L., R. Velazquez-Cruz, R. Urreizti, G. Yoskovitz, P. Sarrion, S. Jurado, et al. 2011. Functional relevance of the BMD-associated polymorphism rs312009: novel involvement of RUNX2 in LRP5 transcriptional regulation. J. Bone Miner. Res. 26:1133-1144.
4. Altmann, S. W., H. R. Jr Davis, X. Yao, M. Laverty, D. S. Compton, L. J. Zhu, et al. 2002. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim. Biophys. Acta 1580:77-93.
5. Badeau, R. M., J. Metso, M. J. Tikkanen, and M. Jauhiainen. 2007. High-density lipoprotein-associated 17beta-estradiol fatty acyl ester uptake by Fu5AH hepatoma cells: implications of the roles of scavenger receptor class B, type I and the low-density lipoprotein receptor. Biochim. Biophys. Acta 1771:1329-1334.
6. Baker, N., G. Zhang, Y. You, and R. S. Tuan. 2012. Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells. J. Cell. Biochem. 113: 3773-3787.
7. Boudin, E., I. Fijalkowski, E. Piters, and W. Van Hul. 2013. The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases. Semin. Arthritis Rheum. 43:220-240.
8. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
9. Brissette, L., M. C. Charest, and L. Falstrault. 1996. Selective uptake of cholesteryl esters of low-density lipoproteins is mediated by the lipoprotein-binding site in HepG2 cells and is followed by the hydrolysis of cholesteryl esters. Biochem. J. 318(Pt 3):841-847.
10. Brodeur, M. R., V. Luangrath, G. Bourret, L. Falstrault, and L. Brissette. 2005. Physiological importance of SR-BI in the in vivo metabolism of human HDL and LDL in male and female mice. J. Lipid Res. 46:687-696.
11. Brodeur, M. R., L. Brissette, L. Falstrault, V. Luangrath, and R. Moreau. 2008a. Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3. J. Bone Miner. Res. 23:326-337.
12. Brodeur, M. R., L. Brissette, L. Falstrault, and R. Moreau. 2008b. HDL3 reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: a protection against cell death. J. Cell. Biochem. 105: 1374-1385.
13. Brodeur, M. R., L. Brissette, L. Falstrault, P. Ouellet, and R. Moreau. 2008c. Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells. Free Radic. Biol. Med. 44:506-517.
14. Clarke, B. 2008. Normal bone anatomy and physiology. Clin. J. Am. Soc. Nephrol. 3(Suppl. 3):S131-S139.
15. Cohen, A. W., R. Hnasko, W. Schubert, and M. P. Lisanti. 2004. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84:1341-1379.
16. Davis, E. K., Y. Zou, and A. Ghosh. 2008. Wnts acting through canonical and noncanonical signaling pathways exert opposite effects on hippocampal synapse formation. Neural. Dev. 3:32.
17. Feng, Y., S. Schouteden, R. Geenens, V. Van Duppen, P. Herijgers, P. Holvoet, et al. 2012. Hematopoietic stem/ progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice. PLoS One. 7:e47286.
18. Frank, P. G., Y. L. Marcel, M. A. Connelly, D. M. Lublin, V. Franklin, D. L. Williams, et al. 2002. Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry 41:11931-11940.
19. Galbiati, F., D. Volonte, J. Liu, F. Capozza, P. G. Frank, Zhu A, et al. 2001. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol. Biol. Cell 12:2229-2244.
20. Gillotte-Taylor, K., A. Boullier, J. L. Witztum, D. Steinberg, and O. Quehenberger. 2001. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J. Lipid Res. 42:1474-1482.
21. Gortazar, A. R., M. Martin-Millan, B. Bravo, L. I. Plotkin, and T. Bellido. 2013. Crosstalk between caveolin-1/extracellular signal-regulated kinase (ERK) and beta-catenin survival pathways in osteocyte mechanotransduction. J. Biol. Chem. 288:8168-8175.
22. Hamel, P., E. Abed, L. Brissette, and R. Moreau. 2008. Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells. Am. J. Physiol. Cell Physiol. 294:C1021-C1033.
23. Hirano, K., S. Yamashita, Y. Nakagawa, T. Ohya, F. Matsuura, K. Tsukamoto, et al. 1999. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ. Res. 85:108-116.
24. Hoekstra, M., D. Ye, R. B. Hildebrand, Y. Zhao, B. Lammers, Stitzinger, et al. 2009. Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. J. Lipid Res. 50:1039-1046.
25. Hulit, J., T. Bash, M. Fu, F. Galbiati, C. Albanese, D. R. Sage, et al. 2000. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 275:21203-21209.
26. Kalajzic, I., A. Staal, W. P. Yang, Y. Wu, S. E. Johnson, J. H. Feyen, et al. 2005. Expression profile of osteoblast lineage at defined stages of differentiation. J. Biol. Chem. 280:24618-24626.
27. Kanatani, N., T. Fujita, R. Fukuyama, W. Liu, C. A. Yoshida, T. Moriishi, et al. 2006. Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. Dev. Biol. 296:48-61.
28. Kim, H. P., X. Wang, A. Nakao, S. I. Kim, N. Murase, M. E. Choi, et al. 2005. Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc. Natl Acad. Sci. USA 102:11319-11324.
29. Komori, T. 2013. Functions of the osteocyte network in the regulation of bone mass. Cell Tissue Res. 352:191-198.
30. Kothapalli, D., I. Fuki, K. Ali, S. A. Stewart, L. Zhao, R. Yahil, et al. 2004. Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation. J. Clin. Invest. 113:609-618.
31. Levy, E., S. Spahis, D. Sinnett, N. Peretti, F. Maupas-Schwalm, E. Delvin, et al. 2007. Intestinal cholesterol transport proteins: an update and beyond. Curr. Opin. Lipidol. 18:310-318.
32. Li, X., Y. Zhang, H. Kang, W. Liu, P. Liu, J. Zhang, et al. 2005. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280:19883-19887.
33. van Lierop, A. H., M. J. Moester, N. A. Hamdy, and S. E. Papapoulos. 2014. Serum Dickkopf 1 levels in sclerostin deficiency. J. Clin. Endocrinol. Metab. 99:E252-E256.
34. Lougheed, M., and U. P. Steinbrecher. 1996. Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation. J. Biol. Chem. 271:11798-11805.
35. Luangrath, V., M. R. Brodeur, D. Rhainds, and L. Brissette. 2008. Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo. Arterioscler. Thromb. Vasc. Biol. 28:1290-1295.
36. Mardones, P., P. Strobel, S. Miranda, F. Leighton, V. Quinones, L. Amigo, et al. 2002. Alpha-tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-BI)-deficient mice. J. Nutr. 132:443-449.
37. Martineau, C., L. Martin-Falstrault, L. Brissette, and R. Moreau. 2014. The atherogenic Scarb1 null mouse model shows a high bone mass phenotype. Am. J. Physiol. Endocrinol. Metab. 306:E48-E57.
38. Meeran, S. M., and S. K. Katiyar. 2008. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci. 13:2191-2202.
39. Miettinen, H. E., H. Rayburn, and M. Krieger. 2001. Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J. Clin. Invest. 108:1717-1722.
40. Mineo, C., and P. W. Shaul. 2012. Functions of scavenger receptor class B, type I in atherosclerosis. Curr. Opin. Lipidol. 23:487-493.
41. Nagajyothi, F., M. Desruisseaux, B. Bouzahzah, L. M. Weiss, D. S. Andrade, S. M. Factor, et al. 2006. Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle 5:107-112.
42. Parton, R. G., M. Hanzal-Bayer, and J. F. Hancock. 2006. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 119: 787-796.
43. Razani, B., J. A. Engelman, X. B. Wang, W. Schubert, X. L. Zhang, C. B. Marks, et al. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276:38121-38138.
44. Razani, B., S. E. Woodman, and M. P. Lisanti. 2002. Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54:431-467.
45. Riddell, D. R., X. M. Sun, A. K. Stannard, A. K. Soutar, and J. S. Owen. 2001. Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane. J. Lipid Res. 42: 998-1002.
46. Rigotti, A., B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger. 1997. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl Acad. Sci. USA 94:12610-12615.
47. Rigotti, A., H. E. Miettinen, and M. Krieger. 2003. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr. Rev. 24:357-387.
48. Roberts, D. C., N. E. Miller, S. G. Price, D. Crook, C. Cortese, A. La Ville, et al. 1985. An alternative procedure for incorporating radiolabelled cholesteryl ester into human plasma lipoproteins in vitro. Biochem. J. 226:319-322.
49. Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D’Amico, R. Pestell, et al. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA 96:5522-5527.
50. Terpos, E., B. Asli, D. Christoulas, J. C. Brouet, E. Kastritis, M. Rybojad, et al. 2012. Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome. Haematologica 97: 1699-1703.
51. Tu, X., Y. Rhee, K. W. Condon, N. Bivi, M. R. Allen, D. Dwyer, et al. 2012. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 50:209-217.
52. Vassiliou, G., F. Benoist, P. Lau, G. N. Kavaslar, and R. McPherson. 2001. The low density lipoprotein receptor-related protein contributes to selective uptake of high density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes. J. Biol. Chem. 276:48823-48830.
53. Xu, J., J. Qian, X. Xie, L. Lin, J. Ma, Z. Huang, et al. 2012a. High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways. Mol. Cell. Biochem. 371:55-64.
54. Xu, J., J. Qian, X. Xie, L. Lin, Y. Zou, M. Fu, et al. 2012b. High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int. J. Mol. Sci. 13:17104-17120.
55. Yamamoto, H., H. Komekado, and A. Kikuchi. 2006. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. Dev. Cell 11:213-223.
56. Yao, G. Q., J. J. Wu, N. Troiano, and K. Insogna. 2011. Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice. J. Bone Miner. Metab. 29:141-148.
57. Yvan-Charvet, L., A. Bobard, P. Bossard, F. Massiera, X. Rousset, G. Ailhaud, et al. 2007. In vivo evidence for a role of adipose tissue SR-BI in the nutritional and hormonal regulation of adiposity and cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 27:1340-1345.
58. Zhang, C. 2012. Molecular mechanisms of osteoblast-specific transcription factor Osterix effect on bone formation. Beijing Da. Xue. Xue. Bao. 44:659-665.
59. Zhang, Y., J. R. Da Silva, M. Reilly, J. T. Billheimer, G. H. Rothblat, and D. J. Rader. 2005. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 115:2870-2874.
60. Zhang, Y., F. C. McGillicuddy, C. C. Hinkle, S. O’Neill, J. M. Glick, G. H. Rothblat, et al. 2010. Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 121:1347-1355.